- COVID-19
- Biosimilars
- Cataract Therapeutics
- DME
- Gene Therapy
- Workplace
- Ptosis
- Optic Relief
- Imaging
- Geographic Atrophy
- AMD
- Presbyopia
- Ocular Surface Disease
- Practice Management
- Pediatrics
- Surgery
- Therapeutics
- Optometry
- Retina
- Cataract
- Pharmacy
- IOL
- Dry Eye
- Understanding Antibiotic Resistance
- Refractive
- Cornea
- Glaucoma
- OCT
- Ocular Allergy
- Clinical Diagnosis
- Technology
EP. 3: EyeCon 2022: High-impact content in a small-scale setting
The setting for this year's Ophthalmology Times® EyeCon 2022 at the JW Marriott Marco Island Beach Resort in Florida will provide the opportunity for clinical interaction between faculty and attendees along with the practicality of information.
This December, Ophthalmology Times® EyeCon 2022 will gather the nation’s leading ophthalmologists to share new data and practical strategies that clinicians can apply to their patients. The conference will take place December 16 to 17 at the JW Marriott Marco Island Beach Resort in Florida.
Co-chairs Peter J. McDonnell, MD, director of the Wilmer Eye Institute at Johns Hopkins University School of Medicine in Baltimore, Maryland, and Oluwatosin U. Smith, MD, of Glaucoma Associates of Texas in Dallas recently spoke with Ophthalmology Times®’ Group Editorial Director Sheryl Stevenson for the top reasons to attend this year's EyeCon 2022. Here is the third in a series of five segments.
To learn more about or to register for Ophthalmology Times® EyeCon 2022, click here.
